Business Context and Reporting Period
This Form 8-K is a current report filed by TRxADE HEALTH, INC. (trading symbol: MEDS) on November 30, 2021. The registrant is an emerging growth company incorporated in Delaware with principal executive offices in Land O' Lakes, Florida. The filing primarily addresses the termination of a material definitive agreement and other corporate restructuring events.
Key Financial Metrics
The filing does not provide specific financial statements, revenue, profit, cash flow, or debt figures for the reporting period. The only financial metric disclosed relates to a terminated capital raising program:
- ATM Program Capacity: $9,000,000 (aggregate offering price authorized).
- Shares Sold: None. No Placement Shares were sold under the agreement prior to termination.
- Termination Penalties: $0. The Company will not incur any penalties for terminating the agreement.
Material Changes
The primary material change reported is the termination of the Equity Distribution Agreement (ATM Program) entered into on August 6, 2021, with EF Hutton, division of Benchmark Investments, LLC. The termination notice was provided on November 30, 2021, and the agreement will officially terminate on December 5, 2021. The Company stated it does not intend to utilize the agreement to raise capital.
Outlook, Management Commentary, and Other Events
Management Commentary: The Company explicitly stated the decision to terminate the ATM Program was due to a lack of intent to raise capital through this specific mechanism.
Other Events (Item 8.01): The Company is consolidating its subsidiary structure. It is in the process of transferring the MedCheks Health Passport app and related intellectual property from its wholly-owned subsidiary MedCheks, LLC, to another wholly-owned subsidiary, Bonum Health, LLC. MedCheks, LLC is planned to be dissolved on or around December 31, 2021. Management notes this transfer has no effect on the app, assets, or rights, serving solely for consolidation purposes.
Investor Verification Checklist
- Verify the effective date of the ATM Program termination (December 5, 2021) and confirm no shares were issued prior to this date.
- Confirm the status of the subsidiary dissolution for MedCheks, LLC and the successful transfer of assets to Bonum Health, LLC by the end of 2021.
- Review the Company's most recent 10-K or 10-Q filings for actual revenue, cash flow, and liquidity positions, as this 8-K does not contain operational financial data.
- Monitor future filings for alternative capital raising strategies given the termination of the ATM Program.